215 possible severe pulmonary disease cases associated with e-cigarette use across 25 states

A surveillance report from public health authorities identified 215 possible cases of severe pulmonary disease associated with the use of electronic cigarette products across 25 states. The report does not specify study design, population characteristics, or follow-up duration. The cases represent possible associations rather than confirmed diagnoses linked to e-cigarette use.

No comparator group was reported, and primary or secondary outcomes were not defined. The main finding is the identification of 215 possible cases, with no effect sizes, p-values, or confidence intervals provided. The direction of association and absolute risk beyond case counts were not reported.

Safety data were limited, with severe pulmonary disease noted as a serious adverse event, but specific adverse events, discontinuation rates, and tolerability were not reported. Key limitations include the absence of confirmed causation, lack of detailed case definitions, and incomplete clinical and exposure data. The report serves as an alert for clinicians to consider e-cigarette use in patients presenting with severe pulmonary symptoms, but does not establish causality or quantify risk.